Nektar Therapeutics (NKTR) dividends
NKTR on Nasdaq, Health Care
Sign in to get an email when it declares a dividend.
Nektar Therapeutics dividend: key facts
Own Nektar Therapeutics? See exactly what it will pay you
Add your shares to a free DiviCompass portfolio to see your next NKTR dividend in your own money, every payment month by month, and an email when it declares. Free for up to 10 holdings, no card needed.
Price history
End-of-day closes on Nasdaq in USD. Dots mark ex-dividend dates.
Dividend history
Declared dividends. Special dividends are marked and excluded from yield and forecasts.
Reported financials
Annual figures from filings, converted to units.
Results, reports and dividend announcements
- Quarterly report (10-Q) (opens in a new tab) · 12 Nov 2026
- NEKTAR THERAPEUTICS: Results of operations (8-K) (opens in a new tab) · 12 Nov 2026
About Nektar Therapeutics
Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.
From Wikipedia, CC BY-SA 4.0.
Next 12 months
No dividends expected from the data available.
Estimate confidence: None
Company news
- NEKTAR THERAPEUTICS: Regulation FD disclosure (8-K)13 Nov 2026 · SEC EDGAR
Insufficient verified data for a financial-health score
Dividend data and price last updated 18 Nov 2026.